Cited by 50Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease

Open access
Beck, Tim N., Nicolas, Emmanuelle, Kopp, Meghan C., Golemis, Erica A.·2014·Oncoscience

Abstract

No treatment strategies effectively limit the progression of Alzheimer's disease (AD), a common and debilitating neurodegenerative disorder. The absence of viable treatment options reflects the fact that the pathophysiology and genotypic causes of the disease are not well understood. The advent of genome-wide association studies (GWAS) has made it possible to broadly investigate genotypic alterations driving phenotypic occurrences. Recent studies have associated single nucleotide polymorphisms (SNPs) in two paralogous scaffolding proteins, NEDD9 and CASS4, and the kinase PTK2B, with susceptibility to late-onset AD (LOAD). Intriguingly, NEDD9, CASS4, and PTK2B have been much studied as interacting partners regulating oncogenesis and metastasis, and all three are known to be active in the brain during development and in cancer. However, to date, the majority of studies of these proteins have emphasized their roles in the directly cancer relevant processes of migration and survival signaling. We here discuss evidence for roles of NEDD9, CASS4 and PTK2B in additional processes, including hypoxia, vascular changes, inflammation, microtubule stabilization and calcium signaling, as potentially relevant to the pathogenesis of LOAD. Reciprocally, these functions can better inform our understanding of the action of NEDD9, CASS4 and PTK2B in cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncoscience.64

Cites

238 of 238 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous SNPs in the CASS4 locus have been linked to AD.

    “Although numerous singlenucleotide polymorphisms (SNPs) in the CASS4 locus have been linked to AD (Beck et al., 2014; Bellenguez et al., 2022; EADB et al., 2026; Lambert et al., 2013; Lin et al., 2017; Schwartzentruber et al., 2021)”

    From Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis (2026) · cites this paper as Beck et al., 2014

    The Introduction’s genetic-evidence section reports that one CASS4 SNP, rs7274581, was associated with late-onset AD at genome-wide significance. Table 1 likewise lists only that CASS4 SNP. The paper therefore supports a CASS4 SNP association, but not the claim that numerous SNPs in the locus have been linked to AD. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • PTK2B encodes the protein PYK2 and is a suggested CASS4-binding partner.

    “Moreover, mutations in the focal adhesion gene PTK2B , which encodes the protein PYK2 and is a suggested CASS4binding partner (Barrett et al., 2013; Beck et al., 2014), have also been linked to increased AD risk in GWAS studies (Lambert et al., 2013; Lin et al., 2017; Ramos de Matos et al., 2018; Schwartzentruber et al., 2021; Wang et al., 2015b).”
  • Pyk2 and CASS4 are members of the FAK and CAS families of proteins that interact physically and mediate cell adhesion signalling.

    “Pyk2 and CASS4 are members of the FAK and CAS families of proteins that interact physically and mediate cell adhesion signalling [8].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 241 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [79]van Seventer GA Salmen HJ Law SF O'Neill GM Mullen MM Franz AM Kanner SB Golemis EA van Seventer JM Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway Eur J Immunol 2001 31 5 1417 1427 11465098

Cited by

Sorted by citations

Authors
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A.
Affiliations
  • Fox Chase Cancer Center (US)
  • Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA
Corresponding author
Golemis, Erica A.
Venue
Oncoscience
Published
2014-07-12
Volume
1
Issue
7
Pages
486-503
ISSN
2331-4737 (ISSN-L)
OpenAlex
W2345736299
Cited by
50
References
241
Citations by year
2026: 4 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 1
FWCI
2.67
Type
journal article
Language
en
Open access
Locations
  • Oncoscience (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TUScholarShare (Temple University) (submittedVersion, cc-by)
Funders
  • National Institutes of Health (CA-06927, CA149147, CA083638)
  • National Cancer Institute (F30CA180607, U54CA149147, P50CA083638, R21CA181287, P30CA006927)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, late-onset Alzheimer's disease, NEDD9, Pyk2, scaffold proteins, single nucleotide polymorphisms, genetic susceptibility, cancer signaling, hypoxia, vascular changes, neuroinflammation, microtubule stabilization, calcium signaling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review